Home

PharmaCyte Biotech, Inc. - Common Stock (PMCB)

1.5600
-0.0200 (-1.27%)

Pharmacyte Biotech Inc is a biotechnology company focused on developing innovative therapies for the treatment of cancer and other serious diseases

The company's primary platform involves utilizing its proprietary cell encapsulation technology, which aims to enhance the effectiveness of existing treatments and create new treatment modalities. By leveraging this technology, Pharmacyte seeks to provide targeted therapies designed to optimize patient outcomes and improve quality of life. The company is actively engaged in research and clinical development to advance its therapeutic candidates and bring them to market.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is PharmaCyte Biotech, Inc. - Common Stock publicly traded?
Yes, PharmaCyte Biotech, Inc. - Common Stock is publicly traded.
What exchange does PharmaCyte Biotech, Inc. - Common Stock trade on?
PharmaCyte Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PharmaCyte Biotech, Inc. - Common Stock?
The ticker symbol for PharmaCyte Biotech, Inc. - Common Stock is PMCB on the Nasdaq Stock Market
What is the current price of PharmaCyte Biotech, Inc. - Common Stock?
The current price of PharmaCyte Biotech, Inc. - Common Stock is 1.560
When was PharmaCyte Biotech, Inc. - Common Stock last traded?
The last trade of PharmaCyte Biotech, Inc. - Common Stock was at 3:43 pm EDT on March 24th, 2025